We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$5.31M
(-1.5%)
Cap. Flow
-$33M
Cap. Flow
% of AUM
-9.71%
Top 10 Holdings %
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$10.1M |
| 2 |
Vale
VALE
|
+$2.39M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.33M |
| 4 |
Coca-Cola
KO
|
+$2.2M |
| 5 |
Wells Fargo
WFC
|
+$1.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$13.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$7.85M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$6.97M |
| 4 |
Logitech
LOGI
|
+$5.93M |
| 5 |
UBS Group
UBS
|
+$5.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.45% |
| 2 | Technology | 13.37% |
| 3 | Healthcare | 13.11% |
| 4 | Financials | 10.95% |
| 5 | Communication Services | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHCT
376
Community Healthcare Trust
CHCT
$530M
| $119K | 0.04% |
2,529
+29
| +1% | +$1.38K |
|
|
VER
377
DELISTED
VEREIT, Inc.
VER
| $118K | 0.03% |
+3,132
| New | +$111K |
|
378
Lamar Advertising Co
LAMR
$16.3B
| $118K | 0.03% |
+1,414
| New | +$106K |
|
379
Teva Pharmaceuticals
TEVA
$41.2B
| $117K | 0.03% |
12,163
+2,302
| +23% | +$22.1K |
|
380
Agree Realty
ADC
$9.42B
| $115K | 0.03% |
1,733
-130
| -7% | -$8.49K |
|
381
Avantor
AVTR
$9.37B
| $114K | 0.03% |
+4,065
| New | +$105K |
|
382
COPT Defense Properties
CDP
$4.35B
| $114K | 0.03% |
4,383
-1,093
| -20% | -$27.6K |
|
|
GTHX
383
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $111K | 0.03% |
6,150
+320
| +5% | +$4.78K |
|
384
Snap-on
SNA
$21.2B
| $109K | 0.03% |
635
+455
| +253% | +$76.1K |
|
385
Sarepta Therapeutics
SRPT
$1.64B
| $108K | 0.03% |
636
| – | – |
|
|
ZGNX
386
DELISTED
Zogenix, Inc.
ZGNX
| $107K | 0.03% |
5,374
+1,210
| +29% | +$24.7K |
|
387
Steel Dynamics
STLD
$36.2B
| $107K | 0.03% |
2,895
-32,303
| -92% | -$1.12M |
|
388
Carnival Corporation Ltd
CCL
$38B
| $106K | 0.03% |
+4,895
| New | +$87K |
|
389
Republic Services
RSG
$65B
| $104K | 0.03% |
1,081
-288
| -21% | -$27.4K |
|
|
RCS
390
PIMCO Strategic Income Fund
RCS
$243M
| $104K | 0.03% |
15,001
| – | – |
|
391
CALL
Deutsche Bank
DB
$69.6B
| $104K | 0.03% |
2,892
-13,652
| -83% | -$141K |
|
392
Vanguard Energy ETF
VDE
$9.97B
| $104K | 0.03% |
2,000
| – | – |
|
393
CVS Health
CVS
$134B
| $103K | 0.03% |
1,511
+12
| +0.8% | +$781 |
|
394
General Motors
GM
$80B
| $102K | 0.03% |
2,442
-34,739
| -93% | -$1.35M |
|
395
Ralph Lauren
RL
$23B
| $99.8K | 0.03% |
962
-2,211
| -70% | -$185K |
|
396
Nuveen Credit Strategies Income Fund
JQC
$705M
| $98.1K | 0.03% |
15,500
| – | – |
|
|
DQ
397
Daqo New Energy
DQ
$819M
| $97.3K | 0.03% |
1,696
+626
| +59% | +$27.3K |
|
398
PTC Therapeutics
PTCT
$6.26B
| $96.5K | 0.03% |
1,582
-2,009
| -56% | -$118K |
|
399
Kodak
KODK
$819M
| $96K | 0.03% |
+11,788
| New | +$98.2K |
|
400
Caterpillar
CAT
$373B
| $95.9K | 0.03% |
+527
| New | +$89.4K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2020 Portfolio in Review
As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.
- Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
- Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
- Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
- Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
- Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
- Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
- Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.
Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.